Company profile: Ritedose
1.1 - Company Overview
Company description
- Provider of pharmaceutical products and services focused on the respiratory market. A leader in blow-fill-seal (BFS) manufacturing of small-fill unit dose sterile and non-sterile liquids for inhalation and ophthalmic use. Offers 503B outsourcing with pre-filled, ready-to-use syringes for hospitals and generic inhalation solutions including cromolyn sodium, albuterol sulfate, and arformoterol tartrate.
Products and services
- 503B Outsourcing: Delivers standards-compliant pre-filled, ready-to-use syringe products for hospitals, addressing drug shortages and ensuring compliance with national standards
- Albuterol Sulfate Inhalation Solution: Offers unit-dose inhalation vials, addressing national drug shortages and used in hospital pharmacies for respiratory conditions
- Blow-Fill-Seal (BFS) Technology: Architects an aseptic system that forms, fills, and seals small-fill volume unit dose sterile/non-sterile liquids, ensuring consistent doses for inhalation and ophthalmic products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ritedose
Euticals
HQ: Italy
Website
- Description: Provider of active pharmaceutical ingredients (APIs), custom synthesis, and fine chemicals. A leading player in the pharmaceutical and fine chemicals industry, with global-scale production, diversified manufacturing plants, and multiple technologies, delivering projects and products in fine chemicals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Euticals company profile →
Metrion Biosciences
HQ: United Kingdom
Website
- Description: Provider of specialist ion channel contract research for drug discovery to pharmaceutical and bioscience customers worldwide, including validated ion channel screening, CiPA-compliant human cardiac ion channel assays (GLP hERG), neuroscience ion channel and neurotoxicology screening, translational phenotypic assays, integrated ion channel research programs, and HTS for hit finding, lead optimization, and selectivity profiling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metrion Biosciences company profile →
LifeScience Logistics
HQ: United States
Website
- Description: Provider of healthcare supply chain solutions, offering FDA-registered, cGMP-compliant warehousing and distribution for medical devices, pharmaceuticals and controlled substances; cold chain storage and logistics (refrigerated, frozen, ultra-low); pick, pack and ship; order-to-cash services; quality assurance and regulatory support; 3PL solutions for manufacturers; and turnkey stockpile solutions for government clients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LifeScience Logistics company profile →
Project Farma
HQ: United States
Website
- Description: Provider of healthcare consulting services to pharmaceutical and medical device manufacturers across the supply chain, including GMP-compliant cell and gene therapy facility builds using modular, bioreactor and single-use technologies; business and manufacturing strategy; turnkey capital projects and project management; validation for GMP/GLP/GCP; quality, regulatory and compliance for ISO/GMP; and engineering and automation solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Project Farma company profile →
KCAS Bio
HQ: United States
Website
- Description: Provider of bioanalytical research services to pharmaceutical, biotech, animal health, and medical device companies, employing carefully validated processes to deliver timely information and insight, giving clients the confidence needed to launch innovative products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KCAS Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ritedose
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ritedose
2.2 - Growth funds investing in similar companies to Ritedose
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ritedose
4.2 - Public trading comparable groups for Ritedose
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →